ACAD could do a $10+ move on the day , one that did in the recent past was VNDA
March 19, 2007
– Comments (1)
Waiting for a pullback on ACAD? ACAD has major Schizophrenia drug Phase II news
Schizophrenia and other psychoses drugs exceeded $15 billion in sales 2005
Schizophrenia is a chronic, debilitating mental illness characterized by disturbances in thinking, emotional reaction, and behavior. These disturbances may include positive symptoms, such as hallucinations and delusions, and a range of negative symptoms, including loss of interest, emotional withdrawal and cognitive disturbances. Approximately one percent of the population develops schizophrenia during their lifetime and more than two million people in the United States suffer from this disease. Worldwide sales of drugs used to treat schizophrenia and other psychoses exceeded $15 billion in 2005. Despite their commercial success, current drugs used to treat schizophrenia have substantial limitations, including severe side effects and a lack of efficacy on all symptoms of the disease.
RSS Headlines
Fool UK